Pericardial effusion requiring pericardiocentesis in a girl with anorexia nervosa.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 16937387)

Published in Int J Eat Disord on November 01, 2006

Authors

Nicoletta Polli1, Simonetta Blengino, Mirella Moro, Daniela Zappulli, Massimo Scacchi, Francesco Cavagnini

Author Affiliations

1: Division of Endocrinology and Metabolic Diseases, University of Milan, Ospedale San Luca IRCCS, Istituto Auxologico Italiano, Milan, Italy.

Articles by these authors

Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis (2007) 2.21

The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 1.73

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53

Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet (2003) 1.47

Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis. J Endovasc Ther (2013) 1.40

Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) (2012) 1.33

Acromegaly. Pituitary (2006) 1.26

Isolated corticotrophin deficiency. Pituitary (2006) 1.11

Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab (2002) 1.11

Caution during use of desmopressin in IPSS. J Neurointerv Surg (2012) 1.07

Hypopituitarism. Pituitary (2006) 1.06

Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab (2003) 1.03

Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY) (2012) 1.01

Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab (2007) 0.99

The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Biotechnol Adv (2011) 0.98

Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab (2003) 0.98

Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95

Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol (2003) 0.93

Potential role for retinoic acid in patients with Cushing's disease. J Clin Endocrinol Metab (2012) 0.92

Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf) (2007) 0.92

Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol (2014) 0.90

Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin Endocrinol (Oxf) (2006) 0.90

Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) (2012) 0.89

Elastosonographic evaluation of thyroid nodules in acromegaly. Eur J Endocrinol (2009) 0.89

Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure. Congest Heart Fail (2011) 0.89

ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry. Endocr Pathol (2012) 0.88

Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol (2011) 0.87

Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf) (2006) 0.86

Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease. Br J Clin Pharmacol (2011) 0.85

Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab (2009) 0.85

Original articles primary coronary angioplasty and subsequent cardiovascular rehabilitation are linked to a favorable sympathovagal balance after a first anterior myocardial infarction. Ital Heart J (2005) 0.84

Meningioma presenting with Cushing's syndrome: an unusual clinical presentation. Ann Neurol (2003) 0.84

High prevalence of prolonged QT interval in obese hypogonadal males. Obesity (Silver Spring) (2011) 0.83

Drugs and HPA axis. Pituitary (2008) 0.83

The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. Eur J Endocrinol (2010) 0.82

Cushing's disease. Pituitary (2006) 0.81

Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report. Endocr J (2010) 0.81

The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol (2009) 0.81

Lymphocytes and immunoglobulin patterns across the threshold of severe obesity. Endocrine (2013) 0.80

Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites. Clin Endocrinol (Oxf) (2008) 0.80

Immunomodulatory effects of VEGF: Clinical implications of VEGF-targeted therapy in human cancer. Cancer Biol Ther (2010) 0.80

Gender-dependent changes in haematological parameters in patients with Cushing's disease before and after remission. Eur J Endocrinol (2014) 0.79

Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure. J Cardiovasc Med (Hagerstown) (2014) 0.78

Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity. Eur J Endocrinol (2003) 0.78

Carney's complex with acromegaly as the leading clinical condition. Clin Endocrinol (Oxf) (2007) 0.78

Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.77

Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease. Clin Exp Pharmacol Physiol (2013) 0.77

Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy. Clin Endocrinol (Oxf) (2012) 0.77

Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease. Eur J Endocrinol (2007) 0.77

Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome. J Clin Endocrinol Metab (2015) 0.77

A new therapeutic strategy against cancer: cAMP elevating drugs and leptin. Cancer Biol Ther (2009) 0.77

AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors. Pituitary (2014) 0.76

Low insulin-like growth factor I and leukopenia in anorexia nervosa. Int J Eat Disord (2008) 0.75

Advances in the medical management of Cushing's syndrome. Expert Opin Pharmacother (2008) 0.75

Potential role of type I interferons in the treatment of pituitary adenomas. Rev Endocr Metab Disord (2008) 0.75

Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory. Pituitary (2009) 0.75

Cushing's disease and pregnancy. Pituitary (2004) 0.75